★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

HOYA Corporation vs Elekta AB (publ)

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

HOYA Corporation

7741 · Tokyo Stock Exchange

Market cap (USD)$57.5B
Gross margin (TTM)79%
Operating margin (TTM)29.6%
Net margin (TTM)26.7%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryJP
Data as of2026-06-03
Moat score
72/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into HOYA Corporation's moat claims, evidence, and risks.

View 7741 analysis

Elekta AB (publ)

EKTA B · NASDAQ Stockholm

Market cap (USD)$2.1B
Gross margin (TTM)37.4%
Operating margin (TTM)5.3%
Net margin (TTM)-3.1%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountrySE
Data as of2026-06-03
Moat score
70/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Elekta AB (publ)'s moat claims, evidence, and risks.

View EKTA B analysis

Comparison highlights

  • Moat score gap: HOYA Corporation leads (72 / 100 vs 70 / 100 for Elekta AB (publ)).
  • Segment focus: HOYA Corporation has 5 segments (47.6% in Eye Health Domain (healthcare-related products)); Elekta AB (publ) has 2 segments (55.8% in Solutions).
  • Moat breadth: HOYA Corporation has 7 moat types across 3 domains; Elekta AB (publ) has 7 across 3.

Primary market context

HOYA Corporation

Eye Health Domain (healthcare-related products)

Market

Ophthalmic products (eyeglass lenses, contact lens retail, intraocular lenses)

Geography

Global (eyeglass lenses & IOL); Japan (contact lens retail)

Customer

Optical retailers, consumers, hospitals/clinics

Role

Manufacturer and retailer

Revenue share

47.6%

Elekta AB (publ)

Solutions

Market

Radiotherapy treatment delivery systems and oncology software solutions (linacs, MR-Linacs, stereotactic radiosurgery, treatment planning & oncology information systems)

Geography

Global

Customer

Hospitals, cancer centers, and clinics (often via public/central procurement)

Role

Medical device OEM + software/platform provider

Revenue share

55.8%

Side-by-side metrics

HOYA Corporation
Elekta AB (publ)
Ticker / Exchange
7741 - Tokyo Stock Exchange
EKTA B - NASDAQ Stockholm
Market cap (USD)
$57.5B
$2.1B
Gross margin (TTM)
79%
37.4%
Operating margin (TTM)
29.6%
5.3%
Net margin (TTM)
26.7%
-3.1%
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
HQ country
JP
SE
Primary segment
Eye Health Domain (healthcare-related products)
Solutions
Market structure
Oligopoly
Oligopoly
Market share
n/a
40%-44% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
72 / 100
70 / 100
Moat domains
Demand, Supply, Legal
Supply, Legal, Demand
Last update
2026-06-03
2026-06-03

Moat coverage

Shared moat types

Compliance Advantage

HOYA Corporation strengths

Brand TrustPhysical Network DensityReputation ReviewsDesign In QualificationLearning Curve YieldNiche speech synthesis portfolio

Elekta AB (publ) strengths

Capex Knowhow ScaleProcurement InertiaData Workflow LockinInstalled Base ConsumablesService Field NetworkSwitching Costs General

Segment mix

HOYA Corporation segments

Full profile >

Eye Health Domain (healthcare-related products)

Oligopoly

47.6%

Med-Tech Domain (medical-related products)

Oligopoly

14.8%

Electronics-related products (semiconductor/display photomask materials, HDD substrates)

Oligopoly

31.2%

Imaging-related products (optical lenses and optical materials)

Competitive

6.2%

Other (speech synthesis software)

Competitive

0.2%

Elekta AB (publ) segments

Full profile >

Solutions

Oligopoly

55.8%

Service

Quasi-Monopoly

44.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.